Insect in IV Solution Prompts Baxter Recall
Baxter has initiated a voluntary recall of two lots of IV solutions due to the potential presence of particulate matter.
Baxter International Inc. announced on July 17 that it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital/user level due to the potential presence of particulate matter.
The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint, the company reports. The matter was identified prior to patient administration and there have been no adverse events associated with this issue reported to Baxter.
This recall affects two lots of 0.9% sodium chloride injection, USP, 50 mL VIAFLEX Plastic Container, a product intended for intravenous use as a source of water and electrolytes. The lots being recalled were distributed to customers and distributors in the United States between Oct. 7, 2014 and July 14, 2015.
Source: Baxter International
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
